Novartis AG OverviewNovartis AG EBIT
EBIT (Earnings Before Interest and Taxes) analysis for NVSEF.
Quarterly EBIT
$3.67B
↓ 21.57% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
$17.37B
↑ 9.09% YoY
Trailing 12 months ending Mar 31, 2026
Novartis AG OverviewEBIT (Earnings Before Interest and Taxes) analysis for NVSEF.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026